Market Closed -
Nyse
01:40:00 08/06/2024 am IST
5-day change
1st Jan Change
0.75
USD
+7.14%
+31.58%
+47.35%
Presentation Operator MessageOperator (Operator)Greetings. Welcome to Know Labs Second Quarter...
Know Labs, Inc. Announces the Appointment of Chris Somogyi as President, International
16/05
CI
Transcript : Know Labs, Inc., Q2 2024 Earnings Call, May 15, 2024
16/05
Know Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
16/05
CI
Know Labs, Inc. to Present Clinical Research At the 2024 American Association of Clinical Endocrinology Annual Meeting
09/05
CI
Certain Common Stock of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 27-MAR-2024.
27/03
CI
Know Labs, Inc. Announces Interim Results from its Most Recent Clinical Research Study
06/03
CI
Know Labs, Inc. announced that it expects to receive $12 million in funding from The Lind Partners, LLC
27/02
CI
Transcript : Know Labs, Inc., Q1 2024 Earnings Call, Feb 14, 2024
15/02
Know Labs, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
15/02
CI
Know Labs, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
20/12
CI
Transcript : Know Labs, Inc., Q4 2023 Earnings Call, Dec 19, 2023
20/12
Know Labs, Inc. Announces Board Appointments
14/12
CI
Know Labs, Inc. Expands Board of Directors
08/11
CI
Transcript : Know Labs, Inc., Q3 2024 Earnings Call, Aug 14, 2023
15/23/15
Know Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
15/23/15
CI
Know Labs, Inc. Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor
26/23/26
CI
Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring
07/23/07
CI
Know Labs, Inc. Furthers External Validation of Bio-RFID(TM) Technology with Study Published in Sensors Journal
18/23/18
CI
Know Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
16/23/16
CI
Know Labs, Inc. Study Validates Technical Feasibility of Its Novel Sensor for Non-Invasive Glucose Monitoring
05/23/05
CI
Know Labs, Inc. Announces Board Appointments
22/23/22
CI
Certain Warrants of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2023.
21/23/21
CI
Certain Convertible Debentures of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2023.
21/23/21
CI
Certain Series D Convertible Preferred Stock of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2023.
21/23/21
CI
Certain Series C Convertible Preferred Stock of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2023.
21/23/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Companyâs Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Companyâs trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.
More about the company
Last Close Price
0.75
USD
Average target price
1
USD
Spread / Average Target
+33.33%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1